Hikma Pharmaceuticals PLC.

In News

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

PR Newswire - Jun 28, 2025

Hikma Pharmaceuticals PLC (LON:HIK) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st

simplywall.st - Jan 10, 2026

Hikma chief steps down after profit forecast cuts and factory delays - Financial Times

Financial Times - Dec 15, 2025

White & Case advises joint lead managers on Hikma Pharmaceuticals’ US$500 million bond issuance - White & Case LLP

White & Case LLP - Jul 23, 2025

Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Yahoo Finance - Sep 19, 2025

Hikma Pharmaceuticals PLC: Quiet Rally, Firm Fundamentals and a Market Looking for the Next Trigger - AD HOC NEWS

AD HOC NEWS - Jan 11, 2026

Hikma Pharmaceutical - Hikma announces CEO change and Board appointment - Research Tree

Research Tree - Dec 15, 2025

Hikma Pharma to pay $50 million to settle narcolepsy drug antitrust case - Reuters

Reuters - May 08, 2025

Hikma Pharmaceuticals: Due a dose of confidence - Proactive financial news

Proactive financial news - Nov 12, 2025

Hikma Pharmaceuticals Reports 6% Revenue Growth And Confirms FY Outlook - DirectorsTalk Interviews

DirectorsTalk Interviews - Aug 07, 2025

Hikma Pharmaceuticals CEO Riad Mishlawi steps down - Investing.com

Investing.com - Dec 15, 2025

Hikma directors restructure pledges over 2.5 million shares via Darhold Limited - TipRanks

TipRanks - Dec 19, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment